GB201608227D0 - Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer - Google Patents
Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancerInfo
- Publication number
- GB201608227D0 GB201608227D0 GBGB1608227.3A GB201608227A GB201608227D0 GB 201608227 D0 GB201608227 D0 GB 201608227D0 GB 201608227 A GB201608227 A GB 201608227A GB 201608227 D0 GB201608227 D0 GB 201608227D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- quinolin
- imidazo
- compounds
- treating cancer
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1608227.3A GB201608227D0 (en) | 2016-05-11 | 2016-05-11 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
| TW106115396A TW201805284A (en) | 2016-05-11 | 2017-05-10 | Imidazo[4,5-C]quinolin-2-one compounds and their use in treating cancer |
| PCT/EP2017/061229 WO2017194632A1 (en) | 2016-05-11 | 2017-05-10 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
| ARP170101261A AR108461A1 (en) | 2016-05-11 | 2017-05-11 | IMIDAZO COMPOUNDS [4,5-C] QUINOLIN-2-ONA AND ITS USE IN CANCER TREATMENT |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1608227.3A GB201608227D0 (en) | 2016-05-11 | 2016-05-11 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201608227D0 true GB201608227D0 (en) | 2016-06-22 |
Family
ID=56297492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1608227.3A Ceased GB201608227D0 (en) | 2016-05-11 | 2016-05-11 | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR108461A1 (en) |
| GB (1) | GB201608227D0 (en) |
| TW (1) | TW201805284A (en) |
| WO (1) | WO2017194632A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019201283A1 (en) * | 2018-04-20 | 2019-10-24 | Xrad Therapeutics, Inc. | Dual atm and dna-pk inhibitors for use in anti-tumor therapy |
| CN110386932A (en) * | 2018-04-20 | 2019-10-29 | 艾科思莱德制药公司 | For the dual ATM and DNA-PK inhibitor in antitumor therapy |
| WO2020052688A1 (en) | 2018-09-14 | 2020-03-19 | Suzhou Zanrong Pharma Limited | 1-ISOPROPYL-3-METHYL-8- (PYRIDIN-3-YL) -1, 3-DIHYDRO-2H-IMIDAZO [4, 5-c] CINNOLIN-2-ONE AS SELECTIVE MODULATORS OF ATAXIA TELANGIECTASIA MUTATED (ATM) KINASE AND USES THEREOF |
| JP6997358B2 (en) * | 2018-09-30 | 2022-01-17 | メッドシャイン ディスカバリー インコーポレイテッド | Kinolinopyrrolidine-2-one-based inducing compounds and their use |
| WO2021098734A1 (en) * | 2019-11-19 | 2021-05-27 | 南京明德新药研发有限公司 | Substituted quinolinopyrrolidone compound as atm inhibitor and application thereof |
| WO2021139814A1 (en) * | 2020-01-09 | 2021-07-15 | 南京明德新药研发有限公司 | Quinoline imidazole compound and application thereof |
| CN115380031A (en) * | 2020-03-30 | 2022-11-22 | 南京明德新药研发有限公司 | Crystal form of quinoline pyrrolidine-2-ketone compound as ATM inhibitor and application thereof |
| WO2021260580A1 (en) | 2020-06-24 | 2021-12-30 | Astrazeneca Uk Limited | Combination of antibody-drug conjugate and atm inhibitor |
| EP3992191A1 (en) | 2020-11-03 | 2022-05-04 | Deutsches Krebsforschungszentrum | Imidazo[4,5-c]quinoline compounds and their use as atm kinase inhibitors |
| WO2023143282A1 (en) * | 2022-01-26 | 2023-08-03 | 正大天晴药业集团股份有限公司 | Hydrazino group-containing compound |
| CN115778962A (en) * | 2022-11-28 | 2023-03-14 | 中国医学科学院肿瘤医院 | Medicine for treating male esophageal cancer patient and related application thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| US6184225B1 (en) | 1996-02-13 | 2001-02-06 | Zeneca Limited | Quinazoline derivatives as VEGF inhibitors |
| DE69709319T2 (en) | 1996-03-05 | 2002-08-14 | Astrazeneca Ab | 4-ANILINOQUINAZOLINE DERIVATIVES |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| CN102372711B (en) | 2010-08-18 | 2014-09-17 | 山东轩竹医药科技有限公司 | Imidazo quinoline PI3K and mTOR (mammalian target of rapamycin) dual inhibitor |
| CN102399218A (en) | 2010-09-16 | 2012-04-04 | 和记黄埔医药（上海）有限公司 | Triheterocyclic compounds and their use as PI3K inhibitors |
| NO2714752T3 (en) * | 2014-05-08 | 2018-04-21 | ||
| GB201516504D0 (en) * | 2015-09-17 | 2015-11-04 | Astrazeneca Ab | Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer |
-
2016
- 2016-05-11 GB GBGB1608227.3A patent/GB201608227D0/en not_active Ceased
-
2017
- 2017-05-10 TW TW106115396A patent/TW201805284A/en unknown
- 2017-05-10 WO PCT/EP2017/061229 patent/WO2017194632A1/en active Application Filing
- 2017-05-11 AR ARP170101261A patent/AR108461A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR108461A1 (en) | 2018-08-22 |
| WO2017194632A1 (en) | 2017-11-16 |
| TW201805284A (en) | 2018-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1257678A1 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| HRP20180697T1 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| HK1257677A1 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| GB201608227D0 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| GB201516504D0 (en) | Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer | |
| ZA201904695B (en) | Amino-triazolopyridine compounds and their use in treating cancer | |
| IL266245B (en) | 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer | |
| GB201604182D0 (en) | Imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| IL269272A (en) | Deuterated imidazo[4,5-c]quinolin-2-one compounds and their use in treating cancer | |
| IL266198A (en) | Liposomal formulation for use in the treatment of cancer | |
| IL261648A (en) | Cinnolin-4-amine compounds and their use in treating cancer | |
| EP2976342A4 (en) | 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer | |
| GB201613403D0 (en) | Pyrrolo[2,3-d]pyrimidin-4-amine compounds and their use in treating cancer | |
| ZA201704727B (en) | New imidazo[1,2-a]quinoxalines and derivates thereof for the treatment of cancer | |
| RS62937B1 (en) | 6,7,8,9-tetrahydro-3h-pyrazolo[4,3-f]isoquinoline derivatives useful in the treatment of cancer | |
| GB201516220D0 (en) | Pyrrolo[2,3-d]pyrimidin-4-amine compounds and their use in treating cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |